Phase II Study of the Dual EGFR/HER3 Inhibitor Duligotuzumab (MEHD7945A) versus Cetuximab in Combination with FOLFIRI in Second-Line RAS Wild-Type Metastatic Colorectal Cancer
| Image |  |
|---|---|
| Description | scientific article published on 5 March 2018 |
| Author/s |
author: Chris Jackson Josep Tabernero Caturla |
| Publication date | March 5, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |